See also this year's filing and all EDGAR filings for this company.
PDF Report 0001444192_2022_Acasti_Pharma_Inc.pdf
Logs
Graph
Absolute values for 0001444192, Acasti Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 62,372,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 86,000 |
| 4 | LiabilitiesCurrent | 1,579,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,219,000 |
| 7 | CostOfGoodsAndServicesSold | 76,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,521,000 |
| 9 | ResearchAndDevelopmentExpense | 4,173,000 |
| 10 | remainder_Expenses | 6,845,000 |
| 11 | remainder_Revenues | 196,000 |
| 12 | remainder_NetIncome | -3,259,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 62,458,000 |
| 1 | Liabilities | 6,798,000 |
| 2 | Expenses | 16,615,000 |
| 3 | Revenues | 196,000 |
| 4 | StockholdersEquity | 55,660,000 |
| 5 | NetIncome | -19,678,000 |
| 6 | ComprehensiveNetIncome | -19,678,000 |
| 7 | BaseVar | 44,663,000 |
| 8 | EconomicCapitalRatio | 2.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
